Crescent Biopharma (CBIO) Return on Assets (2014 - 2026)
Crescent Biopharma (CBIO) posted quarterly Return on Assets of 0.01% for Q2 2026, down 1.0% year-over-year from 0.01% in Q2 2025, and down 16.6% quarter-over-quarter from 0.01% in Q1 2026.
Crescent Biopharma (CBIO) Return on Assets (2014 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported Return on Assets for 13 consecutive years, with 0.01% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Assets fell 1.0% year-over-year to 0.01%; the TTM figure through Jun 2026 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets retreated to 0.01% in Q2 2026 per CBIO's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q3 2025 and bottomed at 0.02% in Q3 2024.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
- Annual changes were most pronounced in 2024 — Return on Assets decreased 1 bps — and 2025, when it rose 1 bps.
- Crescent Biopharma's Return on Assets stood at 0.01% in 2022, then climbed by 14 bps to 0.01% in 2023, then plunged by 152 bps to 0.02% in 2024, then surged by 57 bps to 0.01% in 2025, then sank by 49 bps to 0.01% in 2026.
- Business Quant data shows CBIO's Return on Assets at 0.01% in Q2 2026, 0.01% in Q1 2026, and 0.01% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Crescent Biopharma | 1.05 Bn | 875.92 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |